Physician profile
David Jamison Patton
NPI 1730289513
$11,869.23
in general payments reported to CMS, 2019-2025
29 companies · $992 in 2025
The $992 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $4,847 · 2021: $1,010 · 2022: $702 · 2023: $1,111 · 2024: $2,886 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,393 · Travel and Lodging: $1,482 · Education: $90.05 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,392.87 |
| Travel and Lodging | $1,481.89 |
| Education | $90.05 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,623.96 | 2020-2024 | Da Vinci Surgical System |
| Axonics, INC. | $1,928.87 | 2023-2024 | Axonics, Bulkamid |
| Abbvie INC. | $633.56 | 2019-2025 | |
| Allergan, INC. | $507.24 | 2019-2022 | |
| Astellas Pharma US INC | $389.21 | 2019-2025 | Veozah |
| Shield Therapeutics INC | $374.94 | 2024 | |
| Sage Therapeutics, LLC | $350.67 | 2023-2025 | Zurzuvae |
| Pfizer INC. | $276.46 | 2019-2025 | |
| Novo Nordisk INC | $233.75 | 2019-2025 | Wegovy |
| Ethicon US, LLC | $216.29 | 2021-2025 | Ethicon, Vistaseal, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $155.51 | 2020-2024 | |
| Hologic Sales and Service, LLC | $154.53 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Aspira Women'S Health INC | $150.33 | 2021-2022 | |
| Myovant Sciences INC. | $139.15 | 2021-2022 | |
| Biogen, INC. | $119.33 | 2025 | Zurzuvae |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $109.70 | 2025 | Axonics |
| Galderma Laboratories, L.P. | $87.98 | 2022-2023 | |
| Organon LLC | $69.71 | 2021-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $67.30 | 2024-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $52.63 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $50.77 | 2019-2021 | |
| Coopersurgical, INC. | $38.76 | 2020-2022 | |
| Exeltis, USA INC. | $27.44 | 2021 | |
| Avion Pharmaceuticals | $27.43 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $27.01 | 2019 | |
| Medicem INC. | $18.95 | 2020 | |
| Merck Sharp & Dohme LLC | $13.92 | 2024 | Gardasil 9, Gardasil |
| Acessa Health INC. | $12.15 | 2019 | |
| Therapeuticsmd, INC. | $11.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Patton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.